Literature DB >> 26931558

Prognostic value of right ventricular free wall strain in pulmonary hypertension patients with pseudo-normalized tricuspid annular plane systolic excursion values.

Marco van Kessel1,2, David Seaton3, Jonathan Chan4,5,6, Akira Yamada4,5, Fiona Kermeen7, Christian Hamilton-Craig, Thomas Butler5, Surendran Sabapathy4, Norman Morris4,7.   

Abstract

Pulmonary hypertension (PH) is a progressively fatal disease having a significant impact on right ventricular (RV) function, a major determinant of long-term outcome in PH patients. In our clinic we frequently noticed the combination of PH and reduced RV function, but with discordant Tricuspid Annular Plane Systolic Excursion (TAPSE) values. The present study focuses on whether RV free wall strain measured using 2-dimensional speckle-tracking echocardiography is able to predict mortality in this subgroup of PH patients. 57 patients with PH and RV dysfunction (visual echocardiographic assessment of ≥2) and pseudo-normalized TAPSE values (defined as ≥16 mm) were retrospectively evaluated. Patients were divided by RV free -20 % as cut-off value. Follow-up data on all-cause mortality were registered after a median follow-up time of 27.9 ± 1.7 months. RV free of ≥-20 % was predictive of all-cause mortality after a median follow-up time of 27.9 ± 1.7 months (HR 3.76, 95 % CI 1.02-13.92, p = 0.05). RV free ≥-20 % remained a significant predictor of all-cause mortality (HR 4.30, 95 % CI 1.11-16.61, p = 0.04) after adjusting for PH-specific treatment. On the contrary, TAPSE was not a significant predictor of all-cause mortality. RV free wall strain provides prognostic information in patients with PH and RV dysfunction, but with normal TAPSE values. Future studies with larger cohorts, longer follow-up periods and inclusion of more echocardiographic parameters measuring LV and RV function could confirm the strength of RV free ≥-20 % as a predictor of mortality for this subgroup of patients with PH.

Entities:  

Keywords:  Echocardiography; Mortality; Pulmonary hypertension; Right ventricular function

Mesh:

Year:  2016        PMID: 26931558     DOI: 10.1007/s10554-016-0862-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  35 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

Review 3.  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.

Authors:  François Haddad; Sharon A Hunt; David N Rosenthal; Daniel J Murphy
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

4.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

5.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

6.  Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension.

Authors:  Marlieke L A Haeck; Roderick W C Scherptong; Nina Ajmone Marsan; Eduard R Holman; Martin J Schalij; Jeroen J Bax; Hubert W Vliegen; Victoria Delgado
Journal:  Circ Cardiovasc Imaging       Date:  2012-08-08       Impact factor: 7.792

7.  New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension.

Authors:  Gilles Brierre; Nathalie Blot-Souletie; Bruno Degano; Laurent Têtu; Vanina Bongard; Didier Carrié
Journal:  Eur J Echocardiogr       Date:  2010-02-25

8.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors:  Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

9.  Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension.

Authors:  Benjamin C F Smith; Gary Dobson; David Dawson; Athanasios Charalampopoulos; Julia Grapsa; Petros Nihoyannopoulos
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

10.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

View more
  14 in total

1.  Risk classification of pulmonary arterial hypertension by echocardiographic combined assessment of pulmonary vascular resistance and right ventricular function.

Authors:  Mina Kawamukai; Akiyoshi Hashimoto; Masayuki Koyama; Nobutaka Nagano; Junichi Nishida; Atsushi Mochizuki; Hidemichi Kouzu; Atsuko Muranaka; Nobuaki Kokubu; Daigo Nagahara; Satoshi Yuda; Kazufumi Tsuchihashi; Tetsuji Miura
Journal:  Heart Vessels       Date:  2019-05-22       Impact factor: 2.037

Review 2.  The roles of global longitudinal strain imaging in contemporary clinical cardiology.

Authors:  Toshimitsu Kato; Tomonari Harada; Kazuki Kagami; Masaru Obokata
Journal:  J Med Ultrason (2001)       Date:  2022-01-28       Impact factor: 1.314

Review 3.  Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.

Authors:  Fawaz Alenezi; Taylor A Covington; Monica Mukherjee; Stephen C Mathai; Paul B Yu; Sudarshan Rajagopal
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

4.  Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension.

Authors:  Jiwon Kim; Spencer Krichevsky; Lola Xie; Maria Chiara Palumbo; Sara Rodriguez-Diego; Brian Yum; Lillian Brouwer; Richard T Silver; Andrew I Schafer; Ellen K Ritchie; Maria Mia Yabut; Claudia Sosner; Evelyn M Horn; Richard B Devereux; Joseph M Scandura; Jonathan W Weinsaft
Journal:  J Am Soc Echocardiogr       Date:  2019-10-03       Impact factor: 5.251

5.  The prognostic value of right ventricular deformation derived from cardiac magnetic resonance tissue tracking for all-cause mortality in light-chain amyloidosis patients.

Authors:  Hui Liu; Hang Fu; Ying-Kun Guo; Zhi-Gang Yang; Hua-Yan Xu; Xiao Shuai; Rong Xu; Zhen-Lin Li; Chun-Chao Xia; Yong He; Xiao-Yue Zhou
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

6.  Non-invasive imaging of global and regional cardiac function in pulmonary hypertension.

Authors:  Tim Crowe; Geeshath Jayasekera; Andrew J Peacock
Journal:  Pulm Circ       Date:  2017-10-24       Impact factor: 3.017

7.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

Review 8.  The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases.

Authors:  Marijana Tadic; Nicoleta Nita; Leonhard Schneider; Johannes Kersten; Dominik Buckert; Birgid Gonska; Dominik Scharnbeck; Christine Reichart; Evgeny Belyavskiy; Cesare Cuspidi; Wolfang Rottbauer
Journal:  Front Cardiovasc Med       Date:  2021-06-17

9.  Comparison of tricuspid annular plane systolic excursion with fractional area change for the evaluation of right ventricular systolic function: a meta-analysis.

Authors:  Justin Z Lee; See-Wei Low; Ahmed K Pasha; Carol L Howe; Kwan S Lee; Prakash G Suryanarayana
Journal:  Open Heart       Date:  2018-01-20

10.  Right Ventricular Free Wall Strain and Congestive Hepatopathy in Patients with Acute Worsening of Chronic Heart Failure: A CATSTAT-HF Echo Substudy.

Authors:  Josip A Borovac; Duska Glavas; Zora Susilovic Grabovac; Daniela Supe Domic; Lada Stanisic; Domenico D'Amario; Darko Duplancic; Josko Bozic
Journal:  J Clin Med       Date:  2020-05-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.